These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27030118)

  • 41. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
    Chan GC; Ghazali O; Khoo EM
    Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cholesterol metabolism in patients with type 2 diabetes].
    Vrablík M; Tůmová E
    Vnitr Lek; 2016 Mar; 62(3):189-94. PubMed ID: 27180667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
    Cavender MA; Lincoff AM
    Am J Cardiovasc Drugs; 2010; 10(4):209-16. PubMed ID: 20653327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association.
    Grundy SM; Greenland P; Herd A; Huebsch JA; Jones RJ; Mitchell JH; Schlant RC
    Circulation; 1987 Jun; 75(6):1340A-1362A. PubMed ID: 3552309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.
    Kones R
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):61-81. PubMed ID: 21183531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Moderate exercise reduces the risk of heart disease and death in men with type 2 diabetes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jun; 14(11):10, 12. PubMed ID: 12877117
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association.
    Maahs DM; Daniels SR; de Ferranti SD; Dichek HL; Flynn J; Goldstein BI; Kelly AS; Nadeau KJ; Martyn-Nemeth P; Osganian SK; Quinn L; Shah AS; Urbina E;
    Circulation; 2014 Oct; 130(17):1532-58. PubMed ID: 25170098
    [No Abstract]   [Full Text] [Related]  

  • 48. Type-2 diabetes mellitus and cardiovascular disease.
    Henning RJ
    Future Cardiol; 2018 Nov; 14(6):491-509. PubMed ID: 30409037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
    de Ferranti SD; de Boer IH; Fonseca V; Fox CS; Golden SH; Lavie CJ; Magge SN; Marx N; McGuire DK; Orchard TJ; Zinman B; Eckel RH
    Circulation; 2014 Sep; 130(13):1110-30. PubMed ID: 25114208
    [No Abstract]   [Full Text] [Related]  

  • 50. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.
    Laakso M
    Prim Care; 1999 Dec; 26(4):829-39. PubMed ID: 10523462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of dyslipidemia in patients with diabetes mellitus.
    Pikto-Pietkiewicz W; Wołkowska K; Pasierski T
    Pharmacol Rep; 2005; 57 Suppl():10-9. PubMed ID: 16415483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacotherapy of diabetes mellitus type 2. From the glucocentric tradition towards cardiovascular risk management].
    Jacob S; Marx N
    Internist (Berl); 2006 Apr; 47(4):434, 436-40. PubMed ID: 16523315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. American Heart Association Scientific Sessions 2018.
    Kurian MJ; Rentzepis PJ; Carracher AM; Close KL
    J Diabetes; 2019 Apr; 11(4):261-264. PubMed ID: 30548436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New guidelines for the prevention of cardiovascular disease.
    Klemsdal TO; Gjelsvik B; Elling I; Johansen S; Kjeldsen SE; Kristensen Ø; Madsen S; Njølstad I; Selmer R; Tonstad S; Voie H
    Tidsskr Nor Laegeforen; 2017 Sep; 137(16):. PubMed ID: 28871738
    [No Abstract]   [Full Text] [Related]  

  • 55. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
    de Ferranti SD; de Boer IH; Fonseca V; Fox CS; Golden SH; Lavie CJ; Magge SN; Marx N; McGuire DK; Orchard TJ; Zinman B; Eckel RH
    Diabetes Care; 2014 Oct; 37(10):2843-63. PubMed ID: 25114297
    [No Abstract]   [Full Text] [Related]  

  • 56. Comment on: Impact of a multidisciplinary intensive education program on type 2 diabetes mellitus patients' glycemic control and cardiovascular risk factors.
    Al Saeed AH
    Saudi Med J; 2019 Jan; 40(1):103. PubMed ID: 30617390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperglycemia in patients with acute coronary syndrome: contemporary state of the problem. A scientific statement from the American Heart Association diabetes committee].
    Kobalava ZhD; Tolkacheva VV
    Kardiologiia; 2009; 49(3):77-85. PubMed ID: 19257873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diabetes... and dialogue: shock and happiness].
    Devulder B
    Rev Med Interne; 2004 Oct; 25 Spec No 2():1-2. PubMed ID: 15641502
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular event prevention in the person with type 2 diabetes: case examples for identifying and treating multiple risks.
    Balasubramanyam A; Hinnen D; Polonsky W
    Diabetes Educ; 2006; 32 Suppl 5():163S-173S; quiz 174S-177S. PubMed ID: 16873585
    [No Abstract]   [Full Text] [Related]  

  • 60. A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care.
    Srimanunthiphol J; Beddow R; Arakaki R
    Hawaii Med J; 2000 Jul; 59(7):295-8, 313. PubMed ID: 10961040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.